Search

everythinglearnresearchcommunity

for

Search:↓

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Trichoscopy is useful for diagnosing hair and scalp disorders in people with darker skin.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

Kids with alopecia areata had lower vitamin D levels than healthy kids.

Tofacitinib is an effective and safe treatment for alopecia areata.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

No cure exists for alopecia areata, and treatments are personalized.

Hair loss can significantly impact a person's mental health, causing issues like anxiety and depression, and stress can trigger hair loss.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

FCO2 laser is a better treatment for alopecia areata than intralesional steroids.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Low vitamin D levels are common in people with Alopecia Areata.

Fractional CO2 laser is more effective and safer than steroid injections for treating alopecia areata.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib may help treat severe hair loss, but more research is needed.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.